IL6 and neoplasm: The increased secretion of IL-6 by MUC2-knockdown tumor cells and enhanced tumor growth observed in the present study suggest that the protective mechanisms of MUC2 in colon cancer may be associated with its effects on suppressing the IL-6/STAT3 signaling pathway.